Cis-4-Hydroxy-Lomustine-D10 - Request Quote
Cis-4-Hydroxy-Lomustine-D10
| SZ CAT No: | SZ-L116D03 |
| CAS No | NA |
| Mol.F. | C9H6D10ClN3O3 |
| Mol.Wt. | 259.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cis-4-Hydroxy-Lomustine-D10 is chemically 1-(2-Chloroethyl)-3-((1s,4s)-4-hydroxycyclohexyl-1,2,2,3,3,4,5,5,6,6-d10)-1-nitrosourea. Cis-4-Hydroxy-Lomustine-D10 is supplied with detailed characterization data compliant with regulatory guideline. Cis-4-Hydroxy-Lomustine-D10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lomustine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cis-4-Hydroxy-Lomustine-D10
Purchase Cis-4-Hydroxy-Lomustine-D10
Cis-4-Hydroxy-Lomustine-D10 suppliers
Cis-4-Hydroxy-Lomustine-D10 manufacturers
Cis-4-Hydroxy-Lomustine-D10 price
Order Cis-4-Hydroxy-Lomustine-D10
Enquire Cis-4-Hydroxy-Lomustine-D10
Cis-4-Hydroxy-Lomustine-D10 cost
Cis-4-Hydroxy-Lomustine-D10 Supplier
Cis-4-Hydroxy-Lomustine-D10 Distributor
Cis-4-Hydroxy-Lomustine-D10 for Method Validation
Lomustine Reference Standard
Cis-4-Hydroxy-Lomustine-D10 for ANDA Filing
Cis-4-Hydroxy-Lomustine-D10 for Forced Degradation Studies
Cis-4-Hydroxy-Lomustine-D10 Identification Standards
Cis-4-Hydroxy-Lomustine-D10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


